In patients with chronic liver disease or coagulation disorders, nasogastric tubes may result in significant nasopharyngeal trauma and uncontrolled bleeding. In such patients, use an orogastric tube instead.
In patients with chronic liver disease or coagulation disorders, nasogastric tubes may result in significant nasopharyngeal trauma and uncontrolled bleeding. In such patients, use an orogastric tube instead.
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.